Moderna Surges 177% as Healthcare Sector Defies Drug Pricing Headwinds
Healthcare stocks remain a defensive stronghold as Moderna's clinical success, Pharvaris's upcoming trial data, and AbbVie's dividend reliability offer distinct opportunities for…